- Nexletol is Esperion Therapeutics’ drug, the first oral non-statin approved to treat high cholesterol in nearly 20 years.
- Palforzia is Aimmune Therapeutics’ drug, designed to treat peanut allergies by exposing patients to small amounts of peanut powder.
- Tazverik is Epizyme’s drug, the first treatment that specifically targets epithelioid sarcoma, a rare form of soft tissue cancer.
- Micra AV is the world’s smallest pacemaker with atrioventricular synchrony, made by Medtronic.
- Tepezza is Horizon Therapeutics’ drug, the first designed to treat thyroid eye disease.
More articles on pharmacy:
Walgreens told consultants to erase mention of pharmacists complaints, review finds
Pharmacies need to put value over volume, Cleveland Clinic’s chief pharmacy officer says
Hormone-blocking drug is 8 times more expensive when used for kids, report finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.